Vaxcyte, Inc. ( PCVX) - Stock Earnings
PCVX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
PCVX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -212.8 million USD | — USD |
| 2025Q4 | -246.5 million USD | — USD |
| 2026Q1 | -320.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PCVX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -402.3 million USD | — USD |
| 2024 | -463.9 million USD | — USD |
| 2025 | -766.6 million USD | — USD |
| 2026 Est. | — | — |
PCVX
Price: $54.66
52 week price:
Earnings Per Share: -6.89 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 346400
Market Capitalization: 8.4 billion